Canada Home Healthcare Market is expected to grow with the CAGR of 8.1% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/canada-home-healthcare-market

Canada home healthcare market is a highly consolidated market. The market has witnessed increased strategic developments owing to favorable market scenarios.

The major players dealing in the home health market are introducing strong range of product & services portfolios. This helped companies to maximize sales with enhanced product portfolio.

Medtronic is dominating player in the Canada home healthcare market. The other key players existing in the market includes are Koninklijke Philips N.V., ResMed, Abbott, F. Hoffmann-La Roche Ltd, EXTENDICARE, Bayshore HealthCare, Fresenius Medical Care AG & Co. KGaA, 3M, General Electric Company, Saint Elizabeth Healthcare, Omron Healthcare, Inc. (A Subsidiary of OMRON Corporation), AlayaCare, Siemens Healthcare GmbH, Boston Scientific Corporation, Cardinal Health, Fisher & Paykel Healthcare Limited, Coloplast Canada (A Subsidiary of Coloplast Group), Invacare Corporation, Air Liquide Medical Systems (A subsidiary of Air Liquide) among others.

Medtronic

Medtronic was founded in 1949 and is headquartered in Minneapolis, U.S. The company is engages in development, manufacturing, and sales of medical devices around the globe. The company offers range of product categories including Advanced Surgical Technologies, Cardiac Rhythm, Cardiovascular, Spinal & Orthopedic, Diabetes, Digestive & Gastrointestinal, Ear, Nose & Throat, General Surgery, Patient Monitoring, Urological & Gynecological, Oral, Dental & Maxillofacial, Respiratory Interventions, Renal Care. The company is taking strategic initiatives to increase its portfolio.

• In November 2021, In September, Medtronic received the U.S. Food and Drug Administration (FDA) approval of its MiniMed 770G hybrid closed loop system. This newest insulin pump system offers the company’s most advanced SmartGuard technology, as featured in the MiniMed 670G system, with the added benefits of smartphone connectivity and an expanded age indication down to the age of two years old. This new approval is set to increase the diabetes portfolio and sales of the company.

The company has global presence in North-America, Europe, Middle East and Africa, Asia-Pacific and Medtronic of Canada Ltd. (Canada), Mazor Robotics (Israel), HeartWare International Inc. (U.S.), Titan Spine, Inc. (U.S.), Given Imaging (Israel) among others are the subsidiary of Merck KGaA.

Koninklijke Philips N.V.

Koninklijke Philips N.V. was founded in 1981 and is headquartered in Amsterdam, the Netherlands. The company focuses on d improving people's health from prevention, diagnosis, home care and treatment. Company offers services & products like health informatics, patient monitoring and others. The company offers range of product categories Personal Care, Household products, Sound& Vision, Mother & Child care, Lighting, Accessories, Automotive, Health. The company is taking strategic initiatives to increase its product portfolio.

• In December 2020, the company announced the combination of Philips’ leading patient monitoring position in the hospital with BioTelemetry’s leading cardiac diagnostics and monitoring position outside the hospital. This will result in the company being a global leader in patient care management solutions for the hospital and the home for cardiac and other patients.

The company has global presence in North America, Asia Pacific, South America, Europe, Latin America        . The company has many subsidiaries such as Philips (China) Investment Company, Ltd. (China), Philips Medizin Systeme Boblingen GmbH (Germany), Philips GmbH (Germany), Philips Japan, Ltd. (Japan), Philips Ultrasound, Inc. (U.S.) among others.

ResMed

ResMed was founded in 1989 and is headquartered in California, U.S.. The company is is a global leader in digital health and cloud-connected medical devices. They design innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. The company offers o Devices, Mark System, Diagnostic Products, Connected Solutions and Other Products, SaaS Products of which Devices, SaaS Products are the market focused category. The company is increasing its geographic presence such as:

• In October 2021, ResMed announced the completion of the acquisition of Ectosense a leader in cloud-connected home sleep test (HST) devices that can help millions of people with undiagnosed sleep apnea get the treatment they need – and raise general awareness of the disease. This aided company in strengthening its position in the sleep apnea market

The company has global presence in North America, Asia Pacific, South America, Europe, Latin America. ResMed Asia Pacific Pty Limited (Australia), MatrixCare, Inc (Delaware), Brightree LLC (Delaware), ResMed GmbH and Co KG(Germany) among others are the subsidiary.